 |
|
Comparison of Optical Coherence Tomography Biomarkers between Bevacizumab Good Responders and Nonresponders Who were Switched to Dexamethasone Implant in Diabetic Macular Edema
Jeong Hyun Lee, Joo Young Shin, Jeeyun Ahn
Korean J Ophthalmol. 2023;37(2):137-146. Published online 2023 Mar 23 DOI: https://doi.org/10.3341/kjo.2022.0109
|
|
Citations to this article as recorded by
 Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation
Thomas H. Dohlman, Rohan Bir Singh, Francisco Amparo, Tatiana Carreno-Galeano, Mohammad Dastjerdi, Giulia Coco, Antonio Di Zazzo, Hasanain Shikari, Ujwala Saboo, Kimberly Sippel, Jessica Ciralsky, Sonia H. Yoo, Matheus Sticca, Tais H. Wakamatsu, Somasheil
Ophthalmology Science.2024; 4(4): 100492. CrossRef Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review
Livio Vitiello, Giulio Salerno, Alessia Coppola, Ilaria De Pascale, Giulia Abbinante, Vincenzo Gagliardi, Filippo Lixi, Alfonso Pellegrino, Giuseppe Giannaccare
Life.2024; 14(6): 725. CrossRef
|